Ambri gets new business software
Wednesday, 01 May, 2002
Ambri has adopted new business software and services from Frontstep, to help it to take its new clinical diagnostic system from prototype to full-scale manufacture.
Ambri's CEO and managing director, Joe Shaw, said Frontstep's solution will provide a flexible and highly scalable platform for the company as it moves closer toward establishing commercial manufacturing operations and its North American expansion.
Frontsteps' SyteLine provides a business management platform that will allow Ambri to satisfy the US Food and Drug Administration regulations.
"We will not become a global organisation without people and suppliers who are dedicated to joining with us to achieve this objective," said Shaw.
Plug-and-play test evaluates T cell immunotherapy effectiveness
The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...
CRISPR molecular scissors can introduce genetic defects
CRISPR molecular scissors have the potential to revolutionise the treatment of genetic diseases,...
